The role of (131)I-metaiodobenzylguanidine (MIBG) therapy in unresectable and compromising localised neuroblastoma

por Schoot, Reineke A., Bleeker, Gitta, Caron, Huib N., van Eck, Berthe L., Heij, Hugo A., de Kraker, Jan, Tytgat, Godelieve A.
Publicado 2013

Toxicity of upfront (131)I-metaiodobenzylguanidine ((131)I-MIBG) therapy in newly diagnosed neuroblastoma patients: a retrospective analysis

por Bleeker, Gitta, Schoot, Reineke A., Caron, Huib N., de Kraker, Jan, Hoefnagel, Cees A., van Eck, Berthe L., Tytgat, Godelieve A.
Publicado 2013